Overall hemodynamic studies after the chronic inhibition of endothelial-derived nitric oxide in rats.

[1]  R. Hester,et al.  Systemic and regional hemodynamics after nitric oxide synthase inhibition: role of a neurogenic mechanism. , 1994, The American journal of physiology.

[2]  R. D. Manning,et al.  Long-term cardiovascular role of nitric oxide in conscious rats. , 1994, Hypertension.

[3]  R. D. Manning,et al.  Role of endothelium-derived nitric oxide in control of renal microvasculature in aging male rats. , 1993, The American journal of physiology.

[4]  J. Montani,et al.  Cardiovascular responses to long-term blockade of nitric oxide synthesis. , 1993, Hypertension.

[5]  R. Grekin,et al.  Sustained Hypertension Induced by Orally Administered Nitro‐l‐Arginine , 1993, Hypertension.

[6]  E. Greenblatt,et al.  Marked Regional Heterogeneity in the Magnitude of EDRF/NO‐Mediated Vascular Tone in Awake Rats , 1993, Journal of cardiovascular pharmacology.

[7]  R. Zatz,et al.  Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. , 1992, Hypertension.

[8]  A. Deng,et al.  Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. , 1992, The Journal of clinical investigation.

[9]  O. Carretero,et al.  Sympathetic Modulation of Endothelium‐Derived Relaxing Factor , 1992, Hypertension.

[10]  D. Longnecker,et al.  Inhibition of endothelium-derived relaxing factor-dependent circulatory control in intact rats. , 1992, The American journal of physiology.

[11]  A. Nasjletti,et al.  Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin. , 1992, The Journal of pharmacology and experimental therapeutics.

[12]  H. Gavras,et al.  Inhibition of nitric oxide, bradykinin, and prostaglandins in normal rats. , 1992, Hypertension.

[13]  P. Lacolley,et al.  Role of Sympathetic Nerve Activity in the Generation of Vascular Nitric Oxide in Urethane‐Anesthetized Rats , 1991, Hypertension.

[14]  S. Gardiner,et al.  Regional and cardiac haemodynamic effects of NG‐nitro‐l‐arginine methyl ester in conscious, Long Evans rats , 1990, British journal of pharmacology.

[15]  H. Kontos,et al.  Endothelium-derived relaxing factors. A perspective from in vivo data. , 1990, Hypertension.

[16]  S. Moncada,et al.  Regional haemodynamic changes during oral ingestion of NG‐monomethyl‐l‐arginine or NG‐nitro‐l‐arginine methyl ester in conscious Brattleboro rats , 1990, British journal of pharmacology.

[17]  S. Moncada,et al.  Control of regional blood flow by endothelium-derived nitric oxide. , 1990, Hypertension.

[18]  A. Gibson,et al.  l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro , 1990, British journal of pharmacology.

[19]  S Moncada,et al.  Role of endothelium-derived nitric oxide in the regulation of blood pressure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  O. Griffith,et al.  NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? , 1989, Biochemical and biophysical research communications.

[21]  C. Nathan,et al.  Identification of arginine as a precursor of endothelium-derived relaxing factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[23]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[24]  T. G. Coleman,et al.  Hemodynamic disturbances in the rat as a function of the number of microspheres injected. , 1983, The American journal of physiology.

[25]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[26]  N. Toda,et al.  Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. , 1993, Hypertension.

[27]  Arthur C. Guyton,et al.  Arterial Pressure And Hypertension , 1980 .